Nucleic Acid Testing Market Size, Share, Trends, Growth Outlook

Nucleic Acid Testing Market is estimated to increase at a growth rate of 10.9% CAGR over the forecast period from 2024 to 2030.

The global Nucleic Acid Testing Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Nucleic Acid Test Kits, Consumables), By Indication (Infectious diseases, Cancer, Forensic Testing, Others), By End-User (Hospitals, Pathology laboratories, Research Institutes, Clinics).

An Introduction to Nucleic Acid Testing Market in 2024

Nucleic Acid Testing (NAT) has emerged as a cornerstone of molecular diagnostics, enabling sensitive and specific detection of nucleic acid targets for infectious diseases, genetic disorders, and oncological biomarkers in 2024. The Nucleic Acid Testing Market is witnessing exponential growth and technological advancement as healthcare providers, laboratories, and biotechnology companies harness the power of nucleic acid amplification techniques such as polymerase chain reaction (PCR), transcription-mediated amplification (TMA), and nucleic acid sequence-based amplification (NASBA) for a wide array of clinical applications. With the increasing demand for accurate and rapid diagnostic solutions, there is growing adoption of NAT assays for infectious disease screening, blood transfusion safety, and personalized medicine initiatives. Moreover, the market is characterized by ongoing innovation in sample preparation methods, assay automation, and digital PCR technologies, driving improvements in assay sensitivity, turnaround time, and cost-effectiveness. As the landscape of molecular diagnostics continues to evolve, nucleic acid testing remains at the forefront of diagnostic innovation, offering unparalleled capabilities for disease detection, surveillance, and management.

Nucleic Acid Testing Market Competitive Landscape

The global Nucleic Acid Testing Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, Nucleic Acid Testing Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the Nucleic Acid Testing Industry include- Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Bio-Rad Laboratories Inc, Danaher Corp.

Nucleic Acid Testing Market Trend: Shift Towards Point-of-Care Testing and Molecular Diagnostics

In the Nucleic Acid Testing (NAT) market, a prominent trend is the shift towards point-of-care testing (POCT) and molecular diagnostics. Nucleic acid testing plays a critical role in the diagnosis and monitoring of infectious diseases, genetic disorders, and cancer biomarkers. Recent advancements in nucleic acid amplification technologies, microfluidics, and lab-on-a-chip platforms have enabled the development of rapid, portable, and user-friendly NAT devices for decentralized testing settings. These POCT devices offer advantages such as rapid turnaround time, minimal sample preparation, and high sensitivity, making them well-suited for use in resource-limited settings, community healthcare centers, and outpatient settings. Additionally, the integration of molecular diagnostics into routine clinical practice facilitates early disease detection, accurate diagnosis, and targeted treatment strategies, driving market growth and adoption of NAT platforms in the healthcare industry.

Nucleic Acid Testing Market Driver: Growing Demand for Infectious Disease Screening and Surveillance

The primary market driver for Nucleic Acid Testing is the growing demand for infectious disease screening and surveillance. Infectious diseases pose significant public health challenges worldwide, with outbreaks of emerging pathogens, antimicrobial resistance, and healthcare-associated infections contributing to morbidity and mortality. Nucleic acid testing offers rapid and accurate detection of viral, bacterial, and fungal pathogens, enabling timely diagnosis, outbreak control, and disease surveillance efforts. With the ongoing COVID-19 pandemic highlighting the importance of diagnostic testing in pandemic preparedness and response, there is increased emphasis on scaling up NAT capacity, expanding testing access, and implementing molecular surveillance strategies to monitor viral variants and track transmission dynamics. The growing demand for infectious disease screening and surveillance drives market growth, innovation, and investment in NAT technologies, supporting global health security initiatives and public health interventions.

Nucleic Acid Testing Market Opportunity: Expansion into New Applications and Emerging Markets

An emerging opportunity in the Nucleic Acid Testing market lies in the expansion into new applications and emerging markets. While NAT platforms have traditionally been used for infectious disease diagnostics, there is potential for diversification into other clinical areas, including oncology, pharmacogenomics, and prenatal screening. The adoption of liquid biopsy assays, circulating tumor DNA (ctDNA) analysis, and cell-free nucleic acid testing for cancer detection and monitoring represents a growing market segment within molecular diagnostics. Additionally, expansion into emerging markets, such as Asia-Pacific, Latin America, and Africa, presents opportunities for market growth and penetration of NAT technologies in underserved regions. Factors such as increasing healthcare infrastructure investment, rising awareness of molecular diagnostics, and government initiatives to improve disease surveillance and control contribute to the adoption of NAT platforms in emerging markets. Collaborative partnerships, regulatory harmonization efforts, and technology transfer initiatives are essential for capitalizing on opportunities in new applications and emerging markets, driving market expansion and improving access to nucleic acid testing services globally.

Nucleic Acid Testing Market Share Analysis: Infectious Diseases is the fastest growing market segment over the forecast period to 2030

Among the various products in nucleic acid testing, nucleic acid test kits focused on infectious diseases emerge as the fastest-growing segment. This growth is driven by several factors, including the increasing global burden of infectious diseases, the demand for rapid and accurate diagnostic tools, and advancements in molecular biology techniques. Nucleic acid test kits, particularly those utilizing transcription-mediated amplification (TMA), polymerase chain reaction (PCR), and ligase chain reaction (LCR), offer high sensitivity and specificity in detecting the genetic material of pathogens responsible for infectious diseases. These kits provide healthcare professionals with essential tools for timely diagnosis, surveillance, and management of infectious diseases, enabling early intervention, appropriate treatment decisions, and effective infection control measures. Moreover, the COVID-19 pandemic has further accelerated the adoption of nucleic acid test kits for infectious diseases, highlighting their critical role in pandemic preparedness and response efforts. As the global healthcare community continues to prioritize infectious disease surveillance and control, the demand for nucleic acid test kits for infectious diseases is expected to grow rapidly, driving innovation and advancements in diagnostic technologies to address emerging infectious threats effectively.

Nucleic Acid Testing Market Segmentation

By Product
Nucleic Acid Test Kits
-Transcription-Mediated Amplification (TMA)
-Polymerase Chain Reaction (PCR)
-Ligase Chain Reaction (LCR)
-Whole Genome Sequencing
Consumables
By Indication
Infectious diseases
Cancer
Forensic Testing
Others
By End-User
Hospitals
Pathology laboratories
Research Institutes
Clinics
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

Nucleic Acid Testing Companies

Abbott Laboratories
Agilent Technologies
Becton, Dickinson and Company
Bio-Rad Laboratories Inc
Danaher Corp
* List not Exhaustive

Reasons to Buy the Nucleic Acid Testing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Nucleic Acid Testing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Nucleic Acid Testing Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 Nucleic Acid Testing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Nucleic Acid Testing Market Size Outlook, $ Million, 2021 to 2030
3.2 Nucleic Acid Testing Market Outlook by Type, $ Million, 2021 to 2030
3.3 Nucleic Acid Testing Market Outlook by Product, $ Million, 2021 to 2030
3.4 Nucleic Acid Testing Market Outlook by Application, $ Million, 2021 to 2030
3.5 Nucleic Acid Testing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Nucleic Acid Testing Industry
4.2 Key Market Trends in Nucleic Acid Testing Industry
4.3 Potential Opportunities in Nucleic Acid Testing Industry
4.4 Key Challenges in Nucleic Acid Testing Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global Nucleic Acid Testing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Nucleic Acid Testing Market Outlook by Segments
7.1 Nucleic Acid Testing Market Outlook by Segments, $ Million, 2021- 2030
By Product
Nucleic Acid Test Kits
-Transcription-Mediated Amplification (TMA)
-Polymerase Chain Reaction (PCR)
-Ligase Chain Reaction (LCR)
-Whole Genome Sequencing
Consumables
By Indication
Infectious diseases
Cancer
Forensic Testing
Others
By End-User
Hospitals
Pathology laboratories
Research Institutes
Clinics
8 North America Nucleic Acid Testing Market Analysis and Outlook To 2030
8.1 Introduction to North America Nucleic Acid Testing Markets in 2024
8.2 North America Nucleic Acid Testing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Nucleic Acid Testing Market size Outlook by Segments, 2021-2030
By Product
Nucleic Acid Test Kits
-Transcription-Mediated Amplification (TMA)
-Polymerase Chain Reaction (PCR)
-Ligase Chain Reaction (LCR)
-Whole Genome Sequencing
Consumables
By Indication
Infectious diseases
Cancer
Forensic Testing
Others
By End-User
Hospitals
Pathology laboratories
Research Institutes
Clinics
9 Europe Nucleic Acid Testing Market Analysis and Outlook To 2030
9.1 Introduction to Europe Nucleic Acid Testing Markets in 2024
9.2 Europe Nucleic Acid Testing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Nucleic Acid Testing Market Size Outlook by Segments, 2021-2030
By Product
Nucleic Acid Test Kits
-Transcription-Mediated Amplification (TMA)
-Polymerase Chain Reaction (PCR)
-Ligase Chain Reaction (LCR)
-Whole Genome Sequencing
Consumables
By Indication
Infectious diseases
Cancer
Forensic Testing
Others
By End-User
Hospitals
Pathology laboratories
Research Institutes
Clinics
10 Asia Pacific Nucleic Acid Testing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific Nucleic Acid Testing Markets in 2024
10.2 Asia Pacific Nucleic Acid Testing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Nucleic Acid Testing Market size Outlook by Segments, 2021-2030
By Product
Nucleic Acid Test Kits
-Transcription-Mediated Amplification (TMA)
-Polymerase Chain Reaction (PCR)
-Ligase Chain Reaction (LCR)
-Whole Genome Sequencing
Consumables
By Indication
Infectious diseases
Cancer
Forensic Testing
Others
By End-User
Hospitals
Pathology laboratories
Research Institutes
Clinics
11 South America Nucleic Acid Testing Market Analysis and Outlook To 2030
11.1 Introduction to South America Nucleic Acid Testing Markets in 2024
11.2 South America Nucleic Acid Testing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Nucleic Acid Testing Market size Outlook by Segments, 2021-2030
By Product
Nucleic Acid Test Kits
-Transcription-Mediated Amplification (TMA)
-Polymerase Chain Reaction (PCR)
-Ligase Chain Reaction (LCR)
-Whole Genome Sequencing
Consumables
By Indication
Infectious diseases
Cancer
Forensic Testing
Others
By End-User
Hospitals
Pathology laboratories
Research Institutes
Clinics
12 Middle East and Africa Nucleic Acid Testing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa Nucleic Acid Testing Markets in 2024
12.2 Middle East and Africa Nucleic Acid Testing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Nucleic Acid Testing Market size Outlook by Segments, 2021-2030
By Product
Nucleic Acid Test Kits
-Transcription-Mediated Amplification (TMA)
-Polymerase Chain Reaction (PCR)
-Ligase Chain Reaction (LCR)
-Whole Genome Sequencing
Consumables
By Indication
Infectious diseases
Cancer
Forensic Testing
Others
By End-User
Hospitals
Pathology laboratories
Research Institutes
Clinics
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
Agilent Technologies
Becton, Dickinson and Company
Bio-Rad Laboratories Inc
Danaher Corp
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Nucleic Acid Test Kits
-Transcription-Mediated Amplification (TMA)
-Polymerase Chain Reaction (PCR)
-Ligase Chain Reaction (LCR)
-Whole Genome Sequencing
Consumables
By Indication
Infectious diseases
Cancer
Forensic Testing
Others
By End-User
Hospitals
Pathology laboratories
Research Institutes
Clinics